Keeping Pace in Oncology

Oncology data evolves and emerges at a rapid pace leading to a proliferation of new actionable mutations, therapeutic targets, new therapies, and changes in treatment sequencing. The Keeping Pace in Oncology CME series has been developed to synthesize the latest data from clinical trials to help community oncologists keep pace with the rapid changes and best practices for integrating advances into clinical practice. Educational modules feature conversations with leading experts to explore clinical insights and perspectives on patient-centered treatment.

LikeLikedUnlike

Episodes 1-9 of 9

Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Locally Advanced Disease (Stage IIIB/C)
CME/CE
Keeping Pace in Lung Cancer: Personalizing Treatment in NSCLC: Locally Advanced Disease (Stage IIIB/C)
- Mark Socinski, MD
  Peer
- Kristin Higgins, MD
  Peer
0.25 credits
Keeping Pace in Lung Cancer
Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)
CME/CE
Keeping Pace in Lung Cancer
Personalizing Treatment in NSCLC: Early-Stage Disease (Stage I-IIIa)
- Mark Socinski, MD
  Peer
- Patrick Forde, M.B.B.Ch.
  Peer
0.25 credits
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
CME/CE
Keeping Pace in Hematologic Malignancies: Newly Diagnosed Multiple Myeloma
- Monique Hartley-Brown, MD, MMSc
  Peer
- Shonali Midha, MD
  Peer
0.25 credits
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
CME/CE
Tackling Adverse Events Associated with Disruption of B-Cell Receptor Signaling: A Multispecialty Approach
- Ian W. Flinn, MD, PhD
  Peer
- William Wierda, MD
  Peer
0.25 credits
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
CME/CE
Keeping Pace in Hematologic Malignancies: Novel Targets for Multiple Myeloma
- Cesar Rodriquez Valdes, MD
  Peer
- Amrita Krishnan, MD
  Peer
0.25 credits
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
CME/CE
Keeping Pace in Hematologic Malignancies: Optimizing Treatment Selection in Relapsed or Refractory Multiple Myeloma
- Amrita Krishnan, MD
  Peer
- Morie Gertz, MD, MACP
  Peer
0.25 credits
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
CME/CE
Optimizing Outcomes for Patients with Relapsed or Refractory CLL/SLL
- Jacob D. Soumerai, MD
  Peer
- Andrew H. Lipsky, MD
  Peer
0.25 credits
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
CME/CE
State of the Union: A Targeted Approach in First-Line Treatment of CLL/SLL
- Susan O’Brien, MD
  Peer
- Timothy Call, MD
  Peer
0.25 credits
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
CME/CE
Keeping Pace in Hematologic Malignancies: Updates from ASCO 2022
- Shaji K. Kumar, MD
  Peer
- María-Victoria Mateos, MD, PhD
  Peer
0.25 credits

ReachMD